Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
<p>Abstract</p> <p>Background</p> <p>The prognosis for malignant gliomas remains dismal. We addressed the safety, feasibility and preliminary clinical activity of the vaccinations using autologous glioma cells and interleukin (IL)-4 gene transfected fibroblasts.</p&g...
Main Authors: | Torres-Trejo Alejandro, Hamilton Ronald L, Bejjani Ghassan K, Kondziolka Douglas S, Lunsford L Dade, Walter Kevin A, Lieberman Frank S, Okada Hideho, Kalinski Pawel, Cai Quan, Mabold Jennifer L, Edington Howard D, Butterfield Lisa H, Whiteside Theresa L, Potter Douglas M, Schold S Clifford, Pollack Ian F |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-12-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/5/1/67 |
Similar Items
-
Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma
by: Fujita Mitsugu, et al.
Published: (2007-12-01) -
Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Brian J. Ahn, et al.
Published: (2013-11-01) -
Pediatric Low-Grade Gliomas
by: Kelly L. Collins, et al.
Published: (2020-05-01) -
EphA2 as a Glioma-Associated Antigen: A Novel Target for Glioma Vaccines
by: Manabu Hatano, et al.
Published: (2005-08-01) -
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
by: Pavlina Chuntova, et al.
Published: (2019-01-01)